X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2207) 2207
Publication (417) 417
Book Chapter (26) 26
Book Review (17) 17
Conference Proceeding (6) 6
Magazine Article (6) 6
Dissertation (5) 5
Book / eBook (1) 1
Government Document (1) 1
Reference (1) 1
Trade Publication Article (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
varenicline (1952) 1952
humans (1333) 1333
index medicus (1169) 1169
smoking cessation (905) 905
male (854) 854
smoking cessation - methods (781) 781
female (746) 746
adult (608) 608
smoking (571) 571
middle aged (553) 553
receptor partial agonist (527) 527
nicotine (506) 506
benzazepines - therapeutic use (501) 501
quinoxalines - therapeutic use (498) 498
nicotinic agonists - therapeutic use (486) 486
smoking-cessation (461) 461
sustained-release bupropion (442) 442
smoking cessation programs (431) 431
pharmacology & pharmacy (428) 428
psychiatry (426) 426
bupropion (380) 380
treatment outcome (373) 373
substance abuse (359) 359
tobacco (330) 330
nicotine replacement therapy (321) 321
smokers (320) 320
article (288) 288
benzazepines - adverse effects (285) 285
quinoxalines - adverse effects (284) 284
cessation (276) 276
placebo (276) 276
efficacy (273) 273
bupropion - therapeutic use (270) 270
animals (264) 264
nicotinic agonists - adverse effects (248) 248
neurosciences (238) 238
randomized controlled-trial (237) 237
medicine, general & internal (225) 225
aged (222) 222
tobacco use disorder - drug therapy (213) 213
smoking - drug therapy (210) 210
young adult (208) 208
nicotinic agonists - administration & dosage (206) 206
dependence (194) 194
benzazepines - administration & dosage (192) 192
pharmacotherapy (190) 190
smoking prevention (190) 190
quinoxalines - administration & dosage (189) 189
analysis (187) 187
nicotinic agonists - pharmacology (186) 186
varenicline - therapeutic use (186) 186
public, environmental & occupational health (183) 183
adolescent (181) 181
double-blind method (178) 178
cigarette-smoking (163) 163
nicotine - administration & dosage (163) 163
smoking cessation - psychology (162) 162
tobacco use cessation products (160) 160
double-blind (156) 156
benzazepines - pharmacology (154) 154
care and treatment (152) 152
quinoxalines - pharmacology (152) 152
rats (145) 145
smoking - epidemiology (145) 145
health aspects (144) 144
research (142) 142
nicotine dependence (139) 139
dose-response relationship, drug (138) 138
smoking - psychology (136) 136
drug therapy (134) 134
risk factors (132) 132
abridged index medicus (130) 130
clinical trials (126) 126
partial agonist (122) 122
abstinence (121) 121
smoking - adverse effects (121) 121
therapy (119) 119
addiction (116) 116
risk (114) 114
pharmacology (113) 113
safety (113) 113
smoking - therapy (111) 111
counseling (110) 110
drug addiction (109) 109
alpha-4-beta-2 (107) 107
schizophrenia (106) 106
nicotine - therapeutic use (105) 105
time factors (103) 103
mortality (101) 101
receptors, nicotinic - metabolism (101) 101
usa (95) 95
drugs (94) 94
smoking cessation products (92) 92
tobacco dependence (92) 92
nicotine - pharmacology (89) 89
placebo-controlled trial (89) 89
follow-up studies (88) 88
pharmacology/toxicology (87) 87
intervention (85) 85
united states (85) 85
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2048) 2048
German (50) 50
Spanish (47) 47
French (32) 32
Czech (9) 9
Japanese (9) 9
Korean (6) 6
Polish (6) 6
Dutch (5) 5
Russian (4) 4
Turkish (4) 4
Chinese (3) 3
Portuguese (3) 3
Swedish (3) 3
Danish (2) 2
Italian (2) 2
Romanian (2) 2
Finnish (1) 1
Hungarian (1) 1
Norwegian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


11/2010
Varenicline is used to treat tobacco dependence. While varenicline decreases craving during a quit attempt, no studies have investigated its effect on... 
varenicline | 0419 | cue-induced craving
Dissertation
Cochrane Database of Systematic Reviews, ISSN 1469-493X, 05/2016, Volume 2016, Issue 5, p. CD006103
Background Nicotine receptor partial agonists may help people to stop smoking by a combination of maintaining moderate levels of dopamine to counteract... 
Smoking [drug therapy] | Varenicline | Humans | RANDOMIZED CONTROLLED-TRIAL | Quinolizines [therapeutic use] | PSYCHIATRIC ADVERSE EVENTS | TOBACCO-DEPENDENCE TREATMENT | Quinoxalines [therapeutic use] | MEDICINE, GENERAL & INTERNAL | Bupropion [therapeutic use] | Nicotine [adverse effects; antagonists & inhibitors] | REPLACEMENT THERAPY | SUSTAINED-RELEASE BUPROPION | Smoking Cessation [methods] | Counseling [methods] | VARENICLINE TREATMENT | METHADONE-MAINTAINED SMOKERS | Randomized Controlled Trials as Topic | Azepines [therapeutic use] | DOUBLE-BLIND PLACEBO | Alkaloids [therapeutic use] | Nicotinic Agonists [adverse effects; therapeutic use] | Azocines [therapeutic use] | LONG-TERM SAFETY | Benzazepines [therapeutic use] | PLACEBO-CONTROLLED TRIAL | Substance Withdrawal Syndrome [prevention & control] | Heterocyclic Compounds with 4 or More Rings [therapeutic use] | Quinolizines - therapeutic use | Azepines - adverse effects | Azocines - therapeutic use | Azocines - adverse effects | Substance Withdrawal Syndrome - prevention & control | Alkaloids - adverse effects | Benzazepines - adverse effects | Smoking - drug therapy | Heterocyclic Compounds, 4 or More Rings - adverse effects | Nicotinic Agonists - therapeutic use | Nicotine - antagonists & inhibitors | Smoking Cessation - methods | Azepines - therapeutic use | Nicotine - adverse effects | Nicotinic Agonists - adverse effects | Heterocyclic Compounds, 4 or More Rings - therapeutic use | Benzazepines - therapeutic use | Counseling - methods | Alkaloids - therapeutic use | Quinolizines - adverse effects | Varenicline - therapeutic use | Bupropion - therapeutic use
Journal Article
Clinical Pharmacokinetics, ISSN 0312-5963, 12/2010, Volume 49, Issue 12, pp. 799 - 816
Journal Article
Journal Article
Tobacco Induced Diseases, ISSN 1617-9625, 10/2019, Volume 17, Issue 1
Objective Smokers with diabetes show higher risk for serious microvascular and macrovascular complications, leading them to greater mortality risk. Moreover... 
varenicline | smoking cessation | diabetics
Journal Article
Biological Psychiatry, ISSN 0006-3223, 2010, Volume 67, Issue 8, pp. 715 - 721
Background Cognitive alterations are a core symptom of nicotine withdrawal, contributing to smoking relapse. In rodents and humans, cognitive deficits can be... 
Psychiatry | varenicline | fMRI | nicotine | withdrawal | Addiction | cognition
Journal Article
Journal Article
Neuropharmacology, ISSN 0028-3908, 03/2007, Volume 52, Issue 3, pp. 985 - 994
The preclinical pharmacology of the α4β2 nicotinic acetylcholine receptor (nAChR) partial agonist varenicline, a novel smoking cessation agent is described.... 
Partial agonist | Self-administration | Smoking cessation | Dopamine | nAChR | Varenicline | Nicotine
Journal Article
Journal Article
11/2010
BACKGROUND: Alcohol and tobacco misuse and dependence are highly comorbid disorders. Varenicline alleviates symptoms of cigarette craving while preventing... 
Tobacco | Cue reactivity | Varenicline | 0572 | Alcohol | 0491
Dissertation